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Abstract. Translational research in radiation oncology is 
important for the detection of adverse radiation effects, 
cellular responses, and radiation modifications, and may help 
to improve the outcome of radiation therapy in patients with 
cancer. The present study aimed to optimize and validate a 
real-time label-free assay for the dynamic monitoring of 
cellular responses to ionizing radiation. The xCELLigence 
system is an impedance-based platform that provides contin-
uous information on alterations in cell size, shape, adhesion, 
proliferation, and survival. In the present study, various malig-
nant human primary fibroblast cells (U251, GBM2, MCF7, 
A549, HT‑29) were exposed to 0, 5 and 10 Gy of Cobalt60 radi-
ation. As well as the xCELLigence system, cell survival and 
proliferation was evaluated using the following conventional 
end-point cell-based methods: Clonogenic, MTS, and lactate 
dehydrogenase assays, and apoptosis was detected by fluores-
cence-activated cell sorting. The effects of ionizing radiation 
were detected for each cell line using impedance monitoring. 
The real-time data correlated with the colony forming assay 
results. At low cell densities (1,000‑2,000 cells/well) the 
impedance-based method was more accurate at monitoring 
dose-dependent changes in the malignant human primary 
fibroblast cell lines, as compared with the end‑point assays. 
The results of the present study demonstrated that the 
xCELLigence system may be a reliable and rapid diagnostic 
method for the monitoring of dynamic cell behavior following 
radiation. In addition, the xCELLigence system may be used to 
investigate the cellular mechanisms underlying the radiation 
response, as well as the time-dependent effects of radiation on 
cell proliferation and viability.
Introduction
Translational research in radiation oncology is important for 
the detection of adverse radiation effects, cellular responses, 
and radiation modifications, and may help to improve the 
outcome of radiation therapy in patients with cancer (1). The 
simultaneous administration of chemotherapy and radiation 
therapy may enhance tumor cell destruction, and protec-
tive agents [e.g. Prussian blue, calcium diethylenetriamene 
pentaacetate (DTPA) and zinc DTPA, potassium iodide and 
amifostine] (2) may reduce acute inflammatory reactions 
and healthy tissue complications (3). Further studies on the 
optimization of the dosage and timing of the components 
of such a binary therapeutic system (radiation and radiation 
modifiers) are crucial to the development of novel clinical 
therapeutic strategies (4). Therefore, there is a requirement 
for novel in vitro models that better reflect in vivo conditions, 
which may be reliably transferred into clinical settings. To 
date, limited information is available regarding changes in 
cellular proliferation and viability over time, due to the cyto-
toxicity of certain therapeutic agents, or to ionizing radiation. 
Novel real-time cell analysis platforms allow the continuous 
detection of cell viability during a defined period following 
anti‑cancer treatment (5).
Clonogenic, MTS, and lactate dehydrogenase (LDH) 
assays are well-known end-point methods used for the evalua-
tion of chemoradiation and radiosensitivity.
The clonogenic assay is commonly used to investigate the 
survival and proliferative capacity of irradiated cancer cells. 
The clonogenic assay is used to measure the ability of cells to 
grow in an anchorage-dependent manner. If the cells are able 
to proliferate, they grow in cellular aggregates, referred to as 
colonies. The limiting factor for the use of this method is the 
length of time taken for a colony to form, which may take days 
or weeks. The colonies are then quantified following crystal 
violet staining (6).
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The MTS assay is used to examine the chemosensitivity 
or toxicity of drugs in human tumor cell lines, and to quantify 
the survival of cancer cells following radiation (7). The MTS 
assay is composed of a cell-permeable, soluble tetrazolium 
salt, and an electron coupling reagent (phenazine methosul-
fate) that are added to the cellular environment following 
appropriate dosing periods. During incubation with MTS, the 
dehydrogenase enzymes present within the mitochondria of 
healthy cells reduce the MTS to a dark purple, water-soluble 
formazan compound, which may then be quantified (8,9).
Another method of detecting cytotoxicity is the assessment 
of membrane integrity, which is achieved by monitoring the 
passage of substances that are normally sequestered inside 
cells to the outside of the cells. During the LDH assay, the 
release of LDH from the cytoplasm into the supernatant indi-
cates cell lysis (10).
Previous studies have used cell microelectronic sensing 
to assess the real-time cytoprotective effects of novel drug 
candidates (11), to study the toxicity of various compounds 
in brain endothelial and epithelial cells (12), and to 
dynamically monitor the integrity of experimental biological 
barriers (13‑15).
The xCELLigence system, which was co-developed 
by Roche (Budapest, Hungary) and ACEA Biosciences, 
Inc., (San Diego, CA, USA) provides real‑time continuous 
monitoring and label-free assessment of cellular adhesion, 
morphological changes, proliferation, viability, and cyto-
toxicity, thereby revealing the physiological state of cells. 
The system consists of four main components: A Real-Time 
Cell Analyzer (RTCA), an RTCA Double Plate station, an 
RTCA computer with integrated software, and microtiter 
plates (E‑plate 16). The core of the system is composed of 
disposable microelectronic cell sensor arrays integrated 
into the bottom of the E-plates, which perform cell-based 
assays on the RTCA instrument. The size of the E-plate 16 
corresponds to 1/6 of the size of a 96-well microtiter plate, 
with 16 wells contained in two side by side columns (16,17). 
The electronic impedance of the electrode sensors is 
measured in order to allow the monitoring and detection of 
any alterations in cellular attachment (18,19). The imped-
ance measured between the electrodes in an individual well 
depends on electrode geometry, the ionic concentration of 
the well, and whether the cells are attached to the electrodes. 
In the absence of cells, electrode impedance is predomi-
nantly determined by the ionic environment, both at the 
electrode/solution interface, and in the bulk solution. In the 
presence of cells, the cells attached to the electrode sensor 
surface act as insulators, thereby altering the local ionic 
environment at the electrode/solution interface, leading to an 
increase in impedance. The more cells that have grown on 
the electrodes, the larger the measured electrode impedance. 
The impedance measurement, which is displayed as a cell 
index (CI), provides quantitative information regarding the 
biological status of the cells, including cell number, viability, 
and morphology. Calculation of the cell index is based on the 
following formula: CI = (Zi ‑ Z0)/15, where Zi is the imped-
ance at an individual time point during the experiment, and 
Z0 is the impedance at the start of the experiment. Therefore, 
the CI is a self-calibrated value derived from the ratio of 
impedance. Impedance-based monitoring of cell proliferation 
and viability correlates accurately with cell number (20,21). 
The present study used a 16-well plate system that is able 
to simultaneously measure three independent 16-well plates. 
This allowed the simultaneous investigation of two doses of 
irradiation, together with non-irradiated control cells.
The present study presents the advantages and the poten-
tial uses of the novel xCELLigence biosensor system for the 
measurement of the effects of ionizing radiation on tumor and 
primary cells, as compared with alternative cell-based assays.
Materials and methods
Cell lines and culture conditions. U251 human glioblastoma, 
A549 human lung carcinoma, MCF7 human breast adeno-
carcinoma, HT-29 human colon adenocarcinoma and human 
primary fibroblast cells (passage 4) were all purchased from 
the ATCC (Wesel, Germany), and stored at ‑80˚C in a solu-
tion containing 90% fetal bovine serum (FBS; Gibco Life 
Technologies, Budapest, Hungary) and 10% dimethyl sulf-
oxide (DMSO; Molar Chemicals Kft., Budapest, Hungary). 
GBM2 human glioblastoma cells were obtained from 
Dr Balázs Hegedűs (National Oncology Institute, Budapest, 
Hungary). The human primary fibroblast cells were cultured 
in low glucose Dulbecco's modified Eagle's medium (DMEM; 
Lonza, Budapest, Hungary); the A549, MCF7, HT‑29, and 
GBM2 cells were cultured in DMEM‑F12 (Lonza); and the 
U251 cells were cultured in RPMI‑1640 medium (Lonza) 
supplemented with 10% heat‑inactivated FBS (Gibco Life 
Technologies), 1% L-glutamine, 100 U/ml penicillin, and 
100 µg/ml streptomycin (Sigma‑Aldrich, Budapest, Hungary) 
at 37˚C in a humidified atmosphere containing 5% CO2.
Irradiation. A Teragam K‑01 cobalt unit (SKODA‑ÚJP, 
Prague, Czech Republic) was used (average energy 1.25 MeV; 
source/image distance, 80 cm) to irradiate the cells seeded into 
16‑well E‑plates (Roche), and 96-well and 6-well normal tissue 
culture plates. The plates were surrounded by water on either 
side and placed between two 2 cm polymethyl methacrylate 
slabs to ensure adequate material build‑up. The isocentre was 
positioned at the geometrical centers of the plates. Half of 
the radiation dose was delivered with a downward 20x20 cm 
beam (gantry angle, 0˚), whereas the other half of the radiation 
dose was delivered with an upward 20x20 cm beam (gantry 
angle, 180˚), in order to maximize field homogeneity. The 
delivered doses were 0, 5, and 10 Gy. Due to the decay of 
Cobalt60, irradiation time correction factors were applied.
Clonogenic survival assay. For irradiation experiments, 
the cells were grown in 75 cm2 flasks, until they reached 
75% confluence. The cells were then harvested by trypsiniza-
tion (Sigma‑Aldrich Chemie GmbH, Schnelldorf, Germany), 
and counted using Bürker chambers. The cells were subse-
quently seeded at 1,000 cells/well into 6-well plates, and 
allowed to adhere for 24 h. All clonogenic assay experiments 
were performed in triplicate. During 8 days, the irradiation 
medium was changed every 2 days. The medium was then 
discarded and the cells were washed with phosphate-buffered 
saline (PBS) prior to fixation with 4% paraformaldehyde. 
Colony forming units (CFUs) were stained with a solution 
containing 0.5% crystal violet (Sigma‑Aldrich Chemie 
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GmbH) for 20 min. The plates were rinsed three times with 
tap water and left to dry at room temperature. Colony counting 
was conducted the following day using the Zeiss Axiovert 25 
microscope (Zeiss, Oberkochen, Germany), with the number 
of CFUs expressed as a percentage, as compared with the 
control samples, which were considered 100%.
MTS cell viability assay. The viability of each cell line was 
determined using a colorimetric MTS assay. The cells were 
seeded into 96-well tissue culture plates at a density of 500, 
1,000, 2,000, or 4,000 cells/well, and cultured overnight prior 
to irradiation. Three days following irradiation, 20 µl MTS 
(Gibco Life Technologies) was added at a working concen-
tration of 0.3 mg/ml, and incubated for ≥1 h at 37˚C, in an 
atmosphere containing 5% CO2. Following incubation, the 
absorbance was measured using a Wallac 1420 VICTOR2TM 
ELISA assay plate reader (Wallac VICTOR Plate Reader; 
PerkinElmer, Inc., Waltham, MA, USA) at a wavelength of 
490 nm, with the values expressed in arbitrary units. All MTS 
cell viability experiments were performed in triplicate. 
Lactate dehydrogenase (LDH) assay. A Cytotoxicity 
Detection kit (Roche) was used to assess cell viability 
following irradiation. An LDH assay measures the activity 
levels of LDH in the supernatant released from damaged 
cells, or the activity levels of total LDH following cell 
lysis. The former correlates with the number of dead cells, 
whereas the latter correlates with the number of viable 
cells. For the present study, given the low cell numbers, the 
release assay did not provide sufficient information, likely 
due to the relatively low levels of cell apoptosis, as well as 
the low sensitivity of the assay. Therefore, the total LDH 
activity level detection method was used following cell lysis. 
The cells were seeded at four densities: 500, 1,000, 2,000, 
and 4,000 cells/well. Three days following irradiation, 70 µl 
supernatant was removed from the wells and plated into a 
96-well plate. The remaining medium was discarded. The 
cells were then washed with PBS, and 70 µl PBS containing 
1% Triton X‑100 (Sigma‑Aldrich Chemie GmbH) was added 
to the cells to achieve total cell lysis. Following 15 min incu-
bation at room temperature, 70 µl LDH reagent was added to 
both the lysed cells and the wells containing the supernatant, 
and absorbance at 490 nm was recorded at 2 min intervals for 
a duration of 20 min.
Cell growth and proliferation assay using xCELLigence. 
The cells were grown in 100 mm Petri dishes until they 
had reached 90% confluence; the cells were subsequently 
harvested by trypsinization, and seeded into 16-well E-plates 
at various densities in 100 ml medium (500, 1,000, 2,000, 
4,000 cells/well). Following seeding, the cells were moni-
tored every 10 min by the xCELLigence system (Roche) for 
proliferation, attachment, and spreading. Following 24 h, 
during which time the cells entered the exponential growth 
phase, the cells were irradiated with 5 and 10 Gy doses, and 
impedance detection via the incorporated sensor electrode 
arrays continued for a further 76 h. RTCA Software 2.0 
(Roche) was used to calculate the CI values. The CI values 
were then converted to a percentage 72 h post‑irradiation, 
with the 0 Gy wells being considered 100%.
Apoptosis detection. A total of 5x104 cells were plated onto 
24-well tissue culture plates in triplicate for each time point. 
To detect phosphatidylserine exposure on the outer cell 
membrane, the cells were irradiated with 0, 5, and 10 Gy as 
indicated. Following 24, 48 and 72 h the supernatant was 
collected and mixed with the washed, trypsinized cells, prior 
to incubation with Annexin V binding buffer containing 
0.01 mM HEPES, 0.14 mM NaCl and 2.5 mM CaCl2. 
Annexin V‑Alexa 488 (2.5:100) (Gibco Life Technologies) 
and 10 µg/ml propidium iodide (PI) (Sigma‑Aldrich Chemie 
GmbH) were added to the cells and incubated for 15 min in 
the dark, at room temperature. Following washing, the cells 
were analyzed using a FACSCalibur cytofluorimeter (BD 
Biosciences, San Jose, CA, USA). Annexin V‑Alexa 488 was 
used to determine the percentage of positive cells (FLI), and 
PI was used to determine the percentage of negative early 
apoptotic cells (FL3).
Statistical analysis. Statistical differences between groups 
were assessed with a paired Student's t-test, as analyzed 
using Windows Excel (Microsoft Corporation, Redmond, 
WA, USA). P<0.05 was considered to indicate a statistically 
significant difference (Table I). The data are presented as the 
mean ± standard deviation. 
Results
The present study evaluated the effects of ionizing radiation 
on a wide spectrum of malignant human cell lines and human 
primary fibroblast cells. A systematic comparison of end-point 
and real-time assays was carried out in order to reveal the 
advantages of the xCELLigence system.
GBM2 human glioma cells. The colony forming assay served 
as a reference to assess the effects of radiation on cell growth. 
A strong correlation was detected between irradiation and 
colony formation. Significant differences (P<0.05) were 
observed between the control cells and those exposed to 
5 or 10 Gy irradiation doses. The number of colonies linearly 
decreased with increasing doses of irradiation (Fig. 1). Four 
cell densities were tested using the RTCA (Fig. 2A‑E), MTS 
(Fig. 2F), and LDH (Fig. 2G) assays. The effects of irradiation 
were detected using the label-free method <24 h following 
treatment. At the highest cell density, (4,000 cells/well), the 
cells were overgrown in both the untreated and irradiated 
samples 50 h post‑irradiation (Fig. 2D). Cellular exponential 
growth was arrested due to irradiation at 24 h which was 
recorded as a small plateau at 40-60 h in the cells plated at 
500 and 1,000 cells/well treated with 5 and 10 Gy irradiation. 
Following CI curve normalization (the CI values were scaled 
so that they were independent of initial cell densities) the 
strongest effects of irradiation were observed at the two lowest 
cell densities (Fig. 2A and B). Following 5 Gy irradiation, a 
significant decrease in cellular proliferation was detected, 
whereas at 10 Gy irradiation cellular proliferation ceased 60 h 
post-irradiation. Upon comparison of the results obtained 
from the xCELLigence system and the end-point assays, it was 
apparent that both the LDH and MTS assays (Fig. 2F and G) 
detected a decrease in the overall enzymatic activity at 500, 
1,000 and 2,000 cells/well at 72 h; however, this apparent 
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decrease in enzymatic activity was significantly lower, as 
compared with the impedance measured by the xCELLigence 
system (Fig. 2E). The end-point assays revealed that the effects 
of irradiation decreased with the increasing number of seeded 
cells, except for a density of 4,000 cells/well, as this cell 
density was too high for impedance to occur. The percentage 
of early apoptotic cells was detected by Annexin V binding 
to phosphatidylserine exposed on the outer membrane. The 
percentage of apoptotic cells was correlated with the dose of 
irradiation, and following 10 Gy 12% of cells exhibited early 
apoptosis (Fig. 2H). Discrepancies in the ratios of all param-
eters measured by each assay are due to differences in the 
measured biological targets.
MCF7 human breast adenocarcinoma cells. The results of the 
colony forming assay revealed significant differences between 
the 5 and 10 Gy irradiated cells, and the control cells (Fig. 1). 
In the case of the MTS and LDH assays, all four tested cell 
densities provided results that correlated with these of the 
xCELLigence system (Fig. 3). The MCF7 cells were the most 
radiosensitive of all the experimental cells. Following 5 and 
10 Gy irradiation, the CI values decreased, and after 3 days all 
CI values returned to baseline levels suggesting the presence of 
inhibited cell division and/or marked alterations in cell attach-
ment and shape (Fig. 3A‑E). MTS (Fig. 3F) and LDH (Fig. 3G) 
assays demonstrated a marked decrease in the metabolic 
activity of the cells at all densities, following 72 h irradiation. 
Since the MCF7 cells exhibited high radiosensitivity, ~30% 
of the MCF7 cells underwent early apoptosis following 72 h 
10 Gy irradiation (Fig. 3H).
A549 human lung carcinoma cells. A strong correlation was 
detected between irradiation dosage and colony formation. 
Significant differences (P<0.05) were observed between the 
control cells and those exposed to 5 or 10 Gy irradiation 
(Fig. 1). Using RTCA, MTS and LDH assays, the effects of 
irradiation could be detected at all four experimental cell 
densities (Fig. 4). Seeding densities of 500 or 1,000 cells/well 
proved to be optimal with highly distinguishable growth 
curves, with the rate of cellular proliferation markedly 
decreasing following irradiation, in a dose-dependent manner 
(Fig. 4A, B and E). Seeding densities of 2,000 and 4,000 
cells/well resulted in cell overgrowth over the course of 3 days 
(Fig. 4C, D and E). Although the most pronounced changes 
were apparent with the xCELLigence system, the effects of 
irradiation were also shown to decrease with increasing cell 
density in the MTS (Fig. 4F) and LDH (Fig. 4G) assays. The 
curves generated following 5 and 10 Gy irradiation were 
indistinguishable, exhibiting similar apoptotic rates of 22 and 
22.8%, respectively (Fig. 4H).
HT‑29 human colorectal adenocarcinoma cells. In a similar 
manner to the other cell lines, decreases in HT-29 human 
colorectal adenocarcinoma cell colony growth were also 
dose‑dependent, exhibiting statistically significant differences 
between the control and irradiated groups (Fig. 1). All HT‑29 
cell densities were resistant to all ionizing irradiation doses 
in terms of cell division and/or changes in morphology, as 
determined by the xCELLigence system (Fig. 5A‑E). Lower 
cell densities of 1,000 and 2,000 cells/well exposed to a 10 Gy 
irradiation (Fig. 5A, B and E) exhibited growth inhibition 
and/or detachment, results which were concordant with the 
results from both the MTS and LDH assays. However, in the 
MTS (Fig. 5F) and LDH (Fig. 5G) assays, all cell densities 
showed reduced enzymatic activity due to ionizing radiation. 
As HT‑29 cells showed low sensitivity to the 5 and 10 Gy 
irradiation treatments, only 6 and 10% of the cells were 
Annexin V‑positive, respectively (Fig. 5H).
U251 human glioblastoma cells. Colony forming capacity was 
reduced in a dose-dependent manner following irradiation 
(Fig. 1). A cell density of 500 cells/well did not present suffi-
cient signal throughout the experiment (Fig. 6A), whereas at 
a cell density of 4,000 cells/well, the cells became overgrown 
in 2 days in both the control and irradiated samples (Fig. 6D). 
The results obtained from the RTCA system were signifi-
cant at cell densities of 1,000 and 2,000 cells/well. At 1,000 
cells/well 5 Gy irradiation dose arrested cell proliferation 
and/or influenced cell attachment, whereas irradiation with 
10 Gy led to a decrease in CI values following 48 h (Fig. 6B 
and E). A dose-dependent decrease in the CI values was also 
detectable at a cellular density of 2,000 cells/well, although 
the decrease was less pronounced than at 1,000 cells/well 
(Fig. 6C). The MTS and LDH assays showed a significant 
decrease in the activity levels of dehydrogenases 72 h after 
irradiation, although these results were only observable in 
the LDH assay at a 500 cell/well density (Fig. 6F and G). 
The U251 glioblastoma cell line was moderately sensitive to 
γ‑irradiation, with an apoptotic cell death of 18% following 
10 Gy irradiation (Fig. 6H).
Human primary fibroblasts. Human primary fibroblasts are 
unable to form colonies, and were therefore not examined 
in the colony forming assay. In the RTCA, MTS, and LDH 
assays, the fibroblasts were more resistant to ionizing radiation, 
as compared with the experimental malignant cell lines, even 
following 10 Gy irradiation, following which cellular prolif-
eration was comparable to that of the control cells (Fig. 7A‑G). 
Similarly to the malignant cell lines, xCELLigence analysis 
of the fibroblasts showed sensitivity to cell density, with 500 
Figure 1. Clonogenic survival of the GBM2, MCF7, A549, HT29, and U251 
cells following ionizing radiation. The data are expressed as the mean ± stan-
dard deviation, and all experiments were performed in triplicate. *P<0.05, 
**P<0.01 using the paired Student's t‑test; treated samples vs. 0 Gy (control) 
samples.
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Figure 3. Dynamic monitoring of MCF7 human breast adenocarcinoma cell adhesion and proliferation using the xCELLigence system. The MCF7 cells were 
monitored in 16‑well E‑plates at densities of (A) 500, (B) 1,000, (C) 2,000, and (D) 4,000 cells/well. (E) Cell index values measured by the xCELLigence system 
were converted to a percentage 72 h post‑irradiation. Cells treated with an irradiation dose of 0 Gy were considered 100%. An (F) MTS assay and (G) lactate 
dehydrogenase assay were conducted 72 h following 5 and 10 Gy irradiation. (H) Percentage of early apoptotic cells as detected by Annexin V‑Alexa 488 and 
propidium iodide staining, following 72 h of 5 and 10 Gy irradiation. The data are expressed as the mean ± standard deviation. *P<0.05, **P<0.01 using the 
paired Student’s t‑test; treated samples vs. 0 Gy (control) samples.
Figure 2. Dynamic monitoring of GBM2 human glioma cell adhesion and proliferation using the xCELLigence system. The GBM2 cells were monitored 
in 16‑well E‑plates at densities of (A) 500, (B) 1,000, (C) 2,000, and (D) 4,000 cells/well. (E) Cell index values measured by the xCELLigence system were 
converted to a percentage 72 h post‑irradiation. Cells treated with an irradiation dose of 0 Gy were considered 100%. An (F) MTS assay and (G) lactate 
dehydrogenase assay were conducted 72 h following 5 and 10 Gy irradiation. (H) Percentage of early apoptotic cells as detected by Annexin V‑Alexa 488 and 
propidium iodide staining, following 72 h of 5 and 10 Gy irradiation. The data are expressed as the mean ± standard deviation. *P<0.05, **P<0.01 using the 
paired Student’s t‑test; treated samples vs. 0 Gy (control) samples.
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Figure 4. Dynamic monitoring of A549 human lung carcinoma cell adhesion and proliferation using the xCELLigence system. The A549 cells were monitored 
in 16‑well E‑plates at densities of (A) 500, (B) 1,000, (C) 2,000, and (D) 4,000 cells/well. (E) Cell index values measured by the xCELLigence system were 
converted to a percentage 72 h post‑irradiation. Cells treated with an irradiation dose of 0 Gy were considered 100%. An (F) MTS assay and (G) lactate 
dehydrogenase assay were conducted 72 h following 5 and 10 Gy irradiation. (H) Percentage of early apoptotic cells as detected by Annexin V‑Alexa 488 and 
propidium iodide staining, following 72 h of 5 and 10 Gy irradiation. The data are expressed as the mean ± standard deviation. *P<0.05, **P<0.01 using the 
paired Student’s t‑test; treated samples vs. 0 Gy (control) samples.
Figure 5. Dynamic monitoring of HT‑29 human colorectal adenocarcinoma cell adhesion and proliferation using the xCELLigence system. The HT-29 cells 
were monitored in 16‑well E‑plates at densities of (A) 500, (B) 1,000, (C) 2,000, and (D) 4,000 cells/well. (E) Cell index values measured by the xCELLigence 
system were converted to a percentage 72 h post‑irradiation. Cells treated with an irradiation dose of 0 Gy were considered 100%. An (F) MTS assay and 
(G) lactate dehydrogenase assay were conducted 72 h following 5 and 10 Gy irradiation. (H) Percentage of early apoptotic cells as detected by Annexin V‑Alexa 
488 and propidium iodide staining, following 72 h of 5 and 10 Gy irradiation. The data are expressed as the mean ± standard deviation. *P<0.05, **P<0.01 using 
the paired Student’s t‑test; treated samples vs. 0 Gy (control) samples.
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Figure 6. Dynamic monitoring of U251 human glioblastoma cell adhesion and proliferation using the xCELLigence system. The U251 cells were monitored 
in 16‑well E‑plates at densities of (A) 500, (B) 1,000, (C) 2,000, and (D) 4,000 cells/well. (E) Cell index values measured by the xCELLigence system were 
converted to a percentage 72 h post‑irradiation. Cells treated with an irradiation dose of 0 Gy were considered 100%. An (F) MTS assay and (G) lactate 
dehydrogenase assay were conducted 72 h following 5 and 10 Gy irradiation. (H) Percentage of early apoptotic cells as detected by Annexin V‑Alexa 488 and 
propidium iodide staining, following 72 h of 5 and 10 Gy irradiation. The data are expressed as the mean ± standard deviation. *P<0.05, **P<0.01 using the 
paired Student’s t‑test; treated samples vs. 0 Gy (control) samples.
Figure 7. Dynamic monitoring of human primary fibroblast cell adhesion and proliferation using the xCELLigence system. Human primary fibroblast cells 
were monitored in 16‑well E‑plates at densities of (A) 500, (B) 1,000, (C) 2,000, and (D) 4,000 cells/well. (E) Cell index values measured by the xCELLigence 
system were converted to a percentage 72 h post‑irradiation. Cells treated with an irradiation dose of 0 Gy were considered 100%. An (F) MTS assay and 
(G) lactate dehydrogenase assay were conducted 72 h following 5 and 10 Gy irradiation. (H) Percentage of early apoptotic cells as detected by Annexin V‑Alexa 
488 and propidium iodide staining, following 72 h of 5 and 10 Gy irradiation. The data are expressed as the mean ± standard deviation. *P<0.05, **P<0.01 using 
the paired Student’s t‑test; treated samples vs. 0 Gy (control) samples.
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and 1,000 cells/well being the optimal density, whereas higher 
cellular densities saturated the CI signals prior to the end of 
the assay (Fig. 7A‑D). Concordant with the above-mentioned 
methods, the human primary fibroblast slowly dividing cells 
were resistant to both 5 and 10 Gy irradiation doses, with 1.6 
and 2.5% early apoptotic cells, respectively (Fig. 7H).
Discussion
The study of radiotherapy began in 1896 with the discovery 
of X‑rays by Wilhelm Röntgen. Thereafter, radiation became 
one of the primary strategies for the treatment of numerous 
malignant tumors, through the induction of DNA damage (22). 
The use of radiation as a treatment is based on reports of 
radiation-induced inhibition of cellular proliferation, induc-
tion of apoptotic cell death, and inhibition of tumor growth, 
due to the fact that rapidly dividing malignant cells are more 
radiosensitive, as compared with normal tissue cellular compo-
nents (23). Cell survival following radiation is usually measured 
using end-point assays, and clonogenic and mitochondrial 
dehydrogenase activity assays, such as MTS, are the most 
widely-used methods to carry out such research. However, 
the limitations of end-point assays include the time taken for 
colonies to form, and the inability to measure proliferation of 
primary cells, which do not grow as colonies. The MTS assay 
quantifies metabolically viable cells by measuring their ability 
to reduce a tetrazolium dye. The present study used numerous 
additional methods of cell viability detection following 
irradiation in order to validate the use of the xCELLigence 
system. Given the low cell densities used in the present study 
(500, 1,000, 2,000, and 4,000 cells/well), combined with the 
relatively low rates of cell apoptosis, LDH release into the 
supernatant remained under the detection limit, likely due to 
the low sensitivity of the assay. Therefore, the total LDH detec-
tion method was used following cell lysis, which showed good 
overall correlation with the MTS results. The effects of irradia-
tion were investigated using various methods: The clonogenic 
method relies on CFU capacity, the xCELLigence system 
detects impedance influenced by cell attachment, the MTS and 
LDH assays reflect the metabolic activity levels of viable cells, 
and Annexin V/PI staining determines cell apoptosis rates.
Compared with conventional end-point cell-based assays, 
dynamic monitoring of the cell response, such as cell adhe-
sion, spreading, proliferation, and cell death, is one of the 
advantages of the xCELLigence system. Cell number opti-
mization is usually performed prior to experimentation with 
a given assay; however, in the present study the impact of 
cell density on impedance measurements was demonstrated, 
and 1,000 cells/well was determined to be the optimal cell 
density on the E-plate 16. At higher cell densities the length 
of the assay was limited either by the lack of nutrients in the 
culture media, or by overgrowth of the cells in the well. This 
overgrowth was represented by a plateau in the CI values. The 
impedance-based data detected differences in the radiosen-
sitivity between the various types of human malignant and 
primary cells. As the fastest dividing (data not shown) cells, 
the MCF7 human breast adenocarcinoma cells were the most 
sensitive to γ-rays, corresponding to the lowest metabolic 
activity levels and the highest rates of apoptosis. The GBM2 
human glioblastoma and A549 human lung carcinoma cells 
also showed high radiosensitivity with dose-dependent 
diminished proliferation rates, as determined by the imped-
ance measurements obtained with cell densities of 500 and 
1,000 cells/well. The differences in responsiveness of the 
various cells to ionizing radiation with regards to the investi-
gated parameters is a unique characteristic of each cell type. 
Irradiated GBM2 and A549 cells exhibited high apoptotic 
rates, as well as low dehydrogenase activity at low cell densi-
ties. The U251 human glioblastoma cells were influenced only 
at 1,000 cells/well in the E-plate. Mitochondrial enzymatic 
activity significantly diminished, whereas the levels of LDH, 
a cytoplasmic enzyme, remained unaffected. As radiation 
induces the intrinsic apoptotic pathway, a substantial portion 
(17%) of the cells were apoptotic. HT‑29 human colorectal 
adenocarcinoma cells showed low radiosensitivity irrespective 
of the irradiation dose according to the E-plate measurements, 
whereas mitochondrial and cytoplasmic enzyme activity 
was greatly affected by radiation. As slowly dividing cells, 
human primary fibroblasts proved to be completely resistant 
to γ photons. Impedance, cellular dehydrogenases and phos-
phatidylserine exposure remained unaltered. The insensitivity 
to radiation of the primary fibroblasts may be relevant in 
clinical settings. Tumor‑associated fibroblasts are important 
cellular components of the stroma of solid tumors, inducing 
neovascularization, modulating the immune response, and 
enhancing metastasis (24). Interactions between malignant 
cells and surrounding stromal cells may have an important 
role in tumor invasion and metastasis (25,26). A previous 
study of human retinoblastoma delineated the disadvantages 
of radiotherapy, where following radiation treatment and 
tumor regression, fibrovascular proliferation on the retinal 
surface was observed (27). Radiation of the neoplastic tissues 
surrounded by stromal components may undesirably affect the 
progression of cancer, as irradiated fibroblasts enhance the 
metastatic ability of pancreatic cancer cells (28).
To our knowledge, the present study is the first to demon-
strate the application of the xCELLigence system for the 
determination of the effects of radiation on cells in culture. 
The results obtained using standard end-point assays corre-
lated with the decline of the CI values detected following 
irradiation. However, the end-point assays were only able to 
investigate the reductive capacity of a cell, rather than deter-
mining alterations in cell adherence, shape, and size, which 
are earlier phenotypic changes than cell death itself. 
In conclusion, the present study demonstrated that the 
xCELLigence system is able to detect cell responses to ionizing 
radiation, and provides real-time data on the onset of these 
effects. There are numerous platforms available for the xCEL-
Ligence system: Single plate (SP 96, 1x96 wells), double plate 
(DP 16, 3x16 wells). and multi plate (MP 96, 6x96 wells). The 
multi plate platform offers the possibility of high-throughput 
real-time screening of preclinical drugs in vitro, which influence 
malignant and tumor stromal cell behavior, or examination of the 
response of biopsy-derived cells to radiation with concomitant 
medication ex vivo. A low cell density requirement (1,000 cells) 
is an advantage offered by the xCELLigence system for the 
study of radiation effects, and being a non-invasive, label-free 
and real‑time method, subsequent analysis, such as determina-
tion of DNA or protein expression, or enzyme activity, of the 
investigated cells would be possible.
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